Clinical stage biotech developing cannabinoid-based products.
Industry: Health Care
First Day Return: n/a
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/19/2020 |
Offer Price | $4.50 |
Price Range $4.13 - $4.13 | |
Offer Shares (mm) | 1.8 |
Deal Size ($mm) | $8 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/12/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $8 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Vancouver, Canada |
Founded | 2014 |
Employees at IPO | 11 |
Website www.inmedpharma.com |